Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 1603466 STAMFORD, CT
Back to XFOR Full portfolio

Position in XFOR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$191,806
-$3,040,810 QoQ
Shares Held
41,072
-94.9% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 89 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in XFOR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. XFOR ranks #143 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 4,473,478 $158,316,386
2 CYTK
Cytokinetics Inc
 1,587,712 $135,257,185
3 BBIO
BridgeBio Pharma, Inc.
 1,525,782 $113,640,243
4 AXSM
Axsome Therapeutics, Inc.
 416,516 $101,950,621
5 LEGN
Legend Biotech Corp
 3,076,124 $88,838,461
6 MDGL
Madrigal Pharmaceuticals, Inc.
 137,029 $73,577,721
7 CELC
Celcuity Inc.
 650,916 $68,098,831
8 ACAD
Acadia Pharmaceuticals Inc
 2,433,168 $61,559,150

All Filings in XFOR

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $191,806 41,072
2025-12-31 $3,232,616 808,154
2025-09-30 $74,097 21,666
2025-06-30 $41,167 21,667
2025-03-31 $153,399 650,000
2024-12-31 $477,099 650,000
2024-09-30 $418,159 625,052
2024-06-30 $314,988 543,084
2024-03-31 $903,499 650,000
2023-12-31 $545,349 650,000
2023-09-30 $708,499 650,000
2023-06-30 $1,260,999 650,000
2023-03-31 $565,499 650,000
2022-12-31 $645,449 650,000
2022-09-30 $4,354,422 2,546,446
2022-06-30 $1,576,041 1,633,204
2022-03-31 $2,858,106 1,633,204
2021-12-31 $3,740,037 1,633,204